Literature DB >> 16385233

Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.

Hideyuki Kojima1, Shinya Sakurai, Masahito Uemura, Takashi Takekawa, Hiroyo Morimoto, Yasuhiro Tamagawa, Hiroshi Fukui.   

Abstract

BACKGROUND: Non-alcoholic steatohepatitis (NASH) and alcoholic liver disease (ALD) are extremely similar in the pathologic findings and pathogenesis. This study aimed to elucidate the difference and similarity between these diseases.
METHODS: Twenty-six patients with NASH and 26 with ALD including 11 with alcoholic hepatitis underwent clinico-pathologic analysis. The visceral fat area and liver/spleen ratio, an index of the hepatic fat content, were evaluated with computed tomography. The hepatic iron deposit and oxidative stress induced-lipid peroxidation were estimated by Prussian blue staining and 3-nitrotyrosine staining, respectively.
RESULTS: The most prominent difference between NASH and ALD was the nutritional status, although elevation of AST/ALT ratio and gamma-GT is relatively characteristic of ALD. NASH was more frequently associated with diabetes mellitus as compared with ALD. The BMI and serum levels of total cholesterol and cholinesterase were higher in NASH than in ALD. Although the degree and distribution of fibrosis and necro-inflammatory reaction were similar in NASH and ALD, steatosis was more severe in NASH than in ALD. The liver/spleen ratio was lower and the visceral fat area was larger in NASH than in ALD, regardless of the coincidence of alcoholic hepatitis. Interestingly, the visceral fat area positively correlated with ALT and HOMA-IR in NASH, whereas these correlations were not observed in ALD. The hepatic iron deposit was less in NASH than in ALD, whereas lipid peroxidation in NASH was similar to that in ALD with alcoholic hepatitis and more advanced as compared with that in ALD without alcoholic hepatitis.
CONCLUSIONS: NASH was characterized with over-nutrition and visceral fat type obesity as compared with ALD. The visceral fat accumulation was associated with hepatic inflammation and insulin resistance in NASH, but not in ALD. The difference in the nutritional status between NASH and ALD is not only reflected in the clinical features but also may closely associate with the mechanisms of hepatocellular damage in these diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385233     DOI: 10.1097/01.alc.0000191776.37626.30

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  19 in total

1.  Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.

Authors:  Patricia P Bloom; Amirkasra Mojtahed; Emily D Bethea; Sally A Knooihuizen; Jin Choi; Jules L Dienstag; Raymond T Chung; Chin Hur
Journal:  Dig Dis Sci       Date:  2019-07-30       Impact factor: 3.199

Review 2.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and Adolescents.

Authors:  Victoria Higgins; Arghavan Omidi; Houman Tahmasebi; Shervin Asgari; Kian Gordanifar; Michelle Nieuwesteeg; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.

Authors:  Ali Zarrinpar; Claire M Faltermeier; Vatche G Agopian; Bita V Naini; Michael P Harlander-Locke; Fady M Kaldas; Douglas G Farmer; Ronald W Busuttil
Journal:  Liver Int       Date:  2018-12-02       Impact factor: 5.828

5.  Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study.

Authors:  Stacy A Porter; Alison Pedley; Joseph M Massaro; Ramachandran S Vasan; Udo Hoffmann; Caroline S Fox
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

6.  Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Payal Bhardwaj; Kaushal Madan; Sandeep Thareja; Yogendra Kumar Joshi; Anoop Saraya
Journal:  Hepatol Int       Date:  2008-02-27       Impact factor: 6.047

7.  Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease.

Authors:  Subir Kumar Das; V Balakrishnan
Journal:  Indian J Clin Biochem       Date:  2011-04-07

8.  Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties.

Authors:  David J Orlicky; James R Roede; Elise Bales; Carrie Greenwood; Andrew Greenberg; Dennis Petersen; James L McManaman
Journal:  Alcohol Clin Exp Res       Date:  2011-04-27       Impact factor: 3.455

Review 9.  Fat: a matter of disturbance for the immune system.

Authors:  Alessandro Federico; Elena D'Aiuto; Francesco Borriello; Giusi Barra; Antonietta Gerarda Gravina; Marco Romano; Raffaele De Palma
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

10.  The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.

Authors:  Maxwell Afari Gyamfi; Ivan Damjanov; Samuel French; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2007-10-18       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.